Changes in R&D Schedules and Timing of New Product Launches
First written in FY2016. 21 of 23 entries say "Restated". Latest entry: FY2024-Q1.
The whole theme swung hardest in 2025: 3 of 22 companies on the "Worse" side.
44 other companies' latest entry also says "Restated".
- FY2024-Q1RestatedAnnual report
「During the cumulative first quarter, no new business or other risks arose. In addition, there were no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The company states that there have been no new occurrences or material changes in the risks concerning changes in R&D schedules and new product launch timing. - FY2023RestatedAnnual report
「The group continuously and actively conducts R&D in cutting-edge technologies, primarily in optics, precision machinery and electronics, and seeks to secure leading market shares and high profit margins in each product field it enters by bringing new products incorporating these technologies to market at an early stage. Although we pay close attention to market and customer trends, failure to meet customers’ required technology standards and development schedules, or competitors’ gaining a lead with new products offering a competitive advantage, could cause our products to lose competitiveness, make it difficult to maintain profitability and otherwise affect the performance of the group.」
The company continues to describe the risks of declining competitiveness and profitability due to failure to meet customer requirements and competitors gaining a lead with new products. - FY2023-Q3RestatedAnnual report
「No new business or other risks arose during the cumulative third quarter of the current consolidated fiscal year. There have also been no material changes to the “Business and Other Risks” described in the securities report for the previous fiscal year.」
The company states that there have been no new occurrences or material changes in the risks concerning changes in R&D schedules and new product launch timing. - FY2023-Q2RestatedAnnual report
「During the cumulative second quarter, no new business or other risks arose. In addition, there were no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The company states that there have been no new occurrences or material changes in the risks concerning changes in R&D schedules and new product launch timing. - FY2023-Q1RestatedAnnual report
「During the cumulative first quarter, no new business or other risks arose. In addition, there were no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The company states that there have been no new occurrences or material changes in the risks concerning changes in R&D schedules and new product launch timing. - FY2022-Q2RestatedAnnual report
「During the cumulative second quarter, no new business or other risks arose. In addition, there were no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The company states that there have been no new occurrences or material changes in the risks concerning changes in R&D schedules and new product launch timing. - FY2022-Q1RestatedAnnual report
「During the cumulative first quarter, no new business or other risks arose. In addition, there were no material changes to the business and other risks described in the securities report for the previous fiscal year.」
The company states that there have been no new occurrences or material changes in the risk of changes in R&D schedules and new product launch timing. - FY2021RestatedAnnual report
「The group continuously and actively conducts R&D in cutting-edge technologies, primarily in optics, precision machinery and electronics, and seeks to secure leading market shares and high profit margins in each product field it enters by bringing new products incorporating these technologies to market at an early stage. Although we pay close attention to market and customer trends, failure to meet customers’ required technology standards and development schedules, or competitors’ gaining a lead with new products offering a competitive advantage, could cause our products to lose competitiveness, make it difficult to maintain profitability and otherwise affect the performance of the group.」
The company continues to describe the risks of declining competitiveness and profitability due to failure to meet customer requirements and competitors gaining a lead with new products. It also describes a structure supporting the timely launch of new products, including the establishment of an Advanced Development Office. - FY2021-Q2RestatedAnnual report
「No new business or other risks arose during the six-month period of the current consolidated fiscal year. There were also no material changes to the “Business and Other Risks” described in the securities report for the previous fiscal year.」
The company states that there have been no new occurrences or material changes in the risks concerning changes in R&D schedules and new product launch timing. - FY2020WorsenedAnnual report
「Although we pay close attention to market and customer trends, failure to meet customers’ required technology standards and development schedules, or competitors’ gaining a lead with new products offering a competitive advantage, could cause our products to lose competitiveness, make it difficult to maintain profitability and otherwise affect the performance of the group.」
In addition to the existing risk of changes in development schedules and launch timing, the company now describes risks extending to a loss of competitiveness due to failure to meet customer requirements and competitors gaining a lead. - FY2020-Q3RestatedAnnual report
「No new business or other risks arose during the cumulative third quarter of the current consolidated fiscal year. There have also been no material changes to the “Business and Other Risks” described in the securities report for the previous fiscal year.」
The company states that there have been no new occurrences or material changes in the risk of changes in R&D schedules and new product launch timing. - FY2020-Q2RestatedAnnual report
「No new business or other risks arose during the six-month period of the current consolidated fiscal year. There were also no material changes to the “Business and Other Risks” described in the securities report for the previous fiscal year.」
The company states that there have been no new occurrences or material changes in the risk of changes in R&D schedules and new product launch timing. - FY2019RestatedAnnual report
「Although we pay close attention to market trends and other factors, changes in development schedules and new product launch timing could affect the performance of the group.」
The company continues to identify changes in R&D schedules and new product launch timing as factors that could affect performance. - FY2019-Q3RestatedAnnual report
「No new business or other risks arose during the cumulative third quarter of the current consolidated fiscal year. There have also been no material changes to the “Business and Other Risks” described in the securities report for the previous fiscal year.」
The company states that there have been no new occurrences or material changes in the risk of changes in R&D schedules and new product launch timing. - FY2018RestatedAnnual report
「Although we pay close attention to market trends and other factors, changes in development schedules and new product launch timing could affect the performance of the group.」
The company continues to identify changes in R&D schedules and new product launch timing as factors that could affect performance. - FY2018-Q3RestatedAnnual report
「During the cumulative third quarter, there were no newly arising business or other risks. There were also no material changes in the business and other risks described in the securities report for the previous fiscal year.」
The company states that there have been no new occurrences or material changes in the risk of changes in R&D schedules and new product launch timing. - FY2018-Q2RestatedAnnual report
「No new business or other risks arose during the six-month period of the current consolidated fiscal year. There were also no material changes to the “Business and Other Risks” described in the securities report for the previous fiscal year.」
The company states that there have been no new occurrences or material changes in the risk of changes in R&D schedules and new product launch timing. - FY2018-Q1RestatedAnnual report
「During the cumulative first quarter, there were no newly arising business or other risks. There were also no material changes in the business and other risks described in the securities report for the previous fiscal year.」
The company states that there have been no new occurrences or material changes in the risk of changes in R&D schedules and new product launch timing. - FY2017RestatedAnnual report
「Although we pay close attention to market trends and other factors, changes in development schedules and new product launch timing could affect the performance of the group.」
While continuing R&D in cutting-edge technologies and the early launch of new products, the company continues to identify changes in development schedules and launch timing as risks. - FY2017-Q3RestatedAnnual report
「During the cumulative third quarter, there were no newly arising business or other risks. There were also no material changes in the business and other risks described in the securities report for the previous fiscal year.」
The company states that there have been no new occurrences or material changes in the risks concerning changes in R&D schedules and new product launch timing. - FY2017-Q2RestatedAnnual report
「No new business or other risks arose during the six-month period of the current consolidated fiscal year. There were also no material changes to the “Business and Other Risks” described in the securities report for the previous fiscal year.」
The company states that there have been no new occurrences or material changes in the risks concerning R&D schedules and new product launch timing. - FY2017-Q1RestatedAnnual report
「During the cumulative first quarter, there were no newly arising business or other risks. There were also no material changes in the business and other risks described in the securities report for the previous fiscal year.」
States that no new risks arose and that there were no material changes to existing risks. - FY2016First statedAnnual report
「Although we pay close attention to market trends and other factors, changes in development schedules and new product launch timing could affect the performance of the group.」
While continuing R&D in cutting-edge technologies and advancing their early commercialization, the company recognizes development and launch timing as risks.